Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Psychiatry Res ; 186(2-3): 170-6, 2011 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-20826001

RESUMEN

The mechanisms underlying distortions in sense of agency, i.e. the experience of controlling one's own actions and their consequences, in schizophrenia are not fully understood and have barely been investigated in patients classified as being in a putative psychotic prodrome. This study aims to expound the contribution of early and late illness-related processes. Thirty schizophrenia patients, 30 putatively prodromal patients and 30 healthy controls were instructed to reproduce a computer-generated series of drum sounds on a drum pad. While tapping, subjects heard either their self-produced tones or a computer-controlled reproduction of the drum tone series that used either exactly the same, an accelerated or decelerated tempo. Subjects had to determine the source of agency. Results show similar significant impairments in assigning the source of agency under ambiguous conditions in schizophrenia and putatively prodromal patients and an exaggerated self-attribution bias, both of which were significantly correlated with increased (ego-)psychopathology. Patient groups, however, benefited significantly more than controls from additional sensorimotor cues to agency. Sensorimotor input seems to be a compensatory mechanism involved in correctly attributing agency. We deduce that altered awareness of agency may hold promise as an additional risk factor for psychosis.


Asunto(s)
Trastornos de la Percepción Auditiva/etiología , Concienciación , Trastornos Psicóticos/complicaciones , Trastornos Psicóticos/psicología , Esquizofrenia/complicaciones , Psicología del Esquizofrénico , Estimulación Acústica , Adulto , Sesgo , Señales (Psicología) , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , Escalas de Valoración Psiquiátrica , Psicometría , Sensibilidad y Especificidad , Detección de Señal Psicológica , Adulto Joven
2.
J Clin Psychopharmacol ; 27(2): 156-9, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17414238

RESUMEN

Recent data suggest that inhibitory pathways may be involved in the pathophysiology of depression and in the mode of action of some antidepressant interventions. The aim of the present study was to test whether vagus nerve stimulation (VNS) can affect motor cortex excitability. Measures of motor cortical excitability were probed by using single-pulse and paired-pulse transcranial magnetic stimulation at baseline, after 10 weeks of left VNS, and additionally, in an on-off paradigm in 10 patients with treatment-resistant unipolar depression. Ten weeks of VNS was associated with a selective and pronounced increase in intracortical inhibition, whereas no changes occurred in the on-off paradigm. These results suggest that VNS is capable of changing motor cortical excitability in patients with depression.


Asunto(s)
Trastorno Depresivo/terapia , Estimulación Eléctrica/métodos , Corteza Motora/fisiopatología , Nervio Vago/fisiopatología , Adulto , Benzodiazepinas/uso terapéutico , Citalopram/uso terapéutico , Clomipramina/uso terapéutico , Clozapina/uso terapéutico , Trastorno Depresivo/fisiopatología , Trastorno Depresivo/psicología , Doxepina/uso terapéutico , Quimioterapia Combinada , Estimulación Eléctrica/instrumentación , Femenino , Humanos , Lamotrigina , Carbonato de Litio/uso terapéutico , Masculino , Mianserina/análogos & derivados , Mianserina/uso terapéutico , Persona de Mediana Edad , Mirtazapina , Morfolinas/uso terapéutico , Conducción Nerviosa/efectos de los fármacos , Conducción Nerviosa/fisiología , Inhibición Neural/efectos de los fármacos , Inhibición Neural/fisiología , Olanzapina , Paroxetina/uso terapéutico , Escalas de Valoración Psiquiátrica , Reboxetina , Tranilcipromina/uso terapéutico , Triazinas/uso terapéutico , Ácido Valproico/uso terapéutico
3.
Psychopharmacology (Berl) ; 187(1): 56-9, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16767416

RESUMEN

BACKGROUND: Vagus nerve stimulation (VNS) and repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex are brain stimulation techniques used as therapeutic interventions in major depression. METHODS: In this study, we report the impact of these stimulation techniques on serum concentrations of brain-derived neurotrophic factor (BDNF) in treatment-resistant patients with a diagnosis of major depression. RESULTS: We found no changes of BDNF serum concentrations and no association of neurotrophin concentrations in serum with clinical parameters in our sample. CONCLUSION: Our preliminary results suggest that brain stimulation techniques-in contrast to several antidepressant medications-do not change BDNF serum concentrations.


Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/sangre , Trastorno Depresivo Mayor/terapia , Terapia por Estimulación Eléctrica , Estimulación Magnética Transcraneal , Nervio Vago/fisiología , Adulto , Anciano , Trastorno Depresivo Mayor/sangre , Humanos , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA